Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Nidhi Agarwal

DARK SECRETS: Are pfizer pfe and abbvie abbv good value buys for august | Rare Historical Photos

Demand for new and innovative drugs and widespread adoption of precision medicines is expected to boost the pharma industry. As the industry shows solid potential, quality pharma stock AbbVie Inc. (ABBV) might be a good value buy for August. However, it could be best to wait for a better entry point in Pfizer Inc. (PFE).

Customers in the pharmaceutical market are increasingly looking for personalized and targeted treatments with a focus on preventative healthcare. This has led to a rise in demand for precision medicines tailored to specific genetic profiles and offer more effective treatments with fewer side effects.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.